IT1312083B1 - Derivati morfinoidi, procedimento per la loro preparazione e loroimpiego terapeutico. - Google Patents

Derivati morfinoidi, procedimento per la loro preparazione e loroimpiego terapeutico.

Info

Publication number
IT1312083B1
IT1312083B1 IT1999MI000816A ITMI990816A IT1312083B1 IT 1312083 B1 IT1312083 B1 IT 1312083B1 IT 1999MI000816 A IT1999MI000816 A IT 1999MI000816A IT MI990816 A ITMI990816 A IT MI990816A IT 1312083 B1 IT1312083 B1 IT 1312083B1
Authority
IT
Italy
Prior art keywords
procedure
preparation
therapeutic use
derivatives
morphinoid derivatives
Prior art date
Application number
IT1999MI000816A
Other languages
English (en)
Inventor
Giulio Dondio
Silvano Ronzoni
Luca Francesco Raveglia
Stephen Edward Clarke
Original Assignee
Smithkline Beecham Spa
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT1999MI000816A priority Critical patent/IT1312083B1/it
Application filed by Smithkline Beecham Spa, Smithkline Beecham Plc filed Critical Smithkline Beecham Spa
Priority to AT00927435T priority patent/ATE268773T1/de
Priority to PCT/GB2000/001516 priority patent/WO2000063210A1/en
Priority to DE60011417T priority patent/DE60011417D1/de
Priority to AU45841/00A priority patent/AU4584100A/en
Priority to JP2000612300A priority patent/JP2002542247A/ja
Priority to CO00028934A priority patent/CO5170445A1/es
Priority to EP00927435A priority patent/EP1171441B1/en
Priority to HK02104802.8A priority patent/HK1045150A1/zh
Priority to US09/959,020 priority patent/US6696457B1/en
Publication of ITMI990816A1 publication Critical patent/ITMI990816A1/it
Application granted granted Critical
Publication of IT1312083B1 publication Critical patent/IT1312083B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT1999MI000816A 1999-04-20 1999-04-20 Derivati morfinoidi, procedimento per la loro preparazione e loroimpiego terapeutico. IT1312083B1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT1999MI000816A IT1312083B1 (it) 1999-04-20 1999-04-20 Derivati morfinoidi, procedimento per la loro preparazione e loroimpiego terapeutico.
PCT/GB2000/001516 WO2000063210A1 (en) 1999-04-20 2000-04-19 Morphinoid compounds
DE60011417T DE60011417D1 (de) 1999-04-20 2000-04-19 Morphinoide verbindungen
AU45841/00A AU4584100A (en) 1999-04-20 2000-04-19 Morphinoid compounds
AT00927435T ATE268773T1 (de) 1999-04-20 2000-04-19 Morphinoide verbindungen
JP2000612300A JP2002542247A (ja) 1999-04-20 2000-04-19 モルフィノイド化合物
CO00028934A CO5170445A1 (es) 1999-04-20 2000-04-19 Nuevos compuestos morfinoides,su preparacion y utilizacion
EP00927435A EP1171441B1 (en) 1999-04-20 2000-04-19 Morphinoid compounds
HK02104802.8A HK1045150A1 (zh) 1999-04-20 2000-04-19 類鴉片化合物
US09/959,020 US6696457B1 (en) 1999-04-20 2000-04-20 Morphinoid compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000816A IT1312083B1 (it) 1999-04-20 1999-04-20 Derivati morfinoidi, procedimento per la loro preparazione e loroimpiego terapeutico.

Publications (2)

Publication Number Publication Date
ITMI990816A1 ITMI990816A1 (it) 2000-10-20
IT1312083B1 true IT1312083B1 (it) 2002-04-04

Family

ID=11382772

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI000816A IT1312083B1 (it) 1999-04-20 1999-04-20 Derivati morfinoidi, procedimento per la loro preparazione e loroimpiego terapeutico.

Country Status (10)

Country Link
US (1) US6696457B1 (it)
EP (1) EP1171441B1 (it)
JP (1) JP2002542247A (it)
AT (1) ATE268773T1 (it)
AU (1) AU4584100A (it)
CO (1) CO5170445A1 (it)
DE (1) DE60011417D1 (it)
HK (1) HK1045150A1 (it)
IT (1) IT1312083B1 (it)
WO (1) WO2000063210A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040067950A1 (en) * 1998-07-27 2004-04-08 Schering-Plough Corporation High affinity ligands for nociceptin receptor ORL-1
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
US20060069086A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
EP2931726B1 (en) * 2012-12-14 2017-01-25 Purdue Pharma LP Spirocyclic morphinans and their use
ES2631197T3 (es) * 2012-12-14 2017-08-29 Purdue Pharma Lp Análogos de piridonamorfinano y actividad biológica sobre los receptores opiodes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270612B (it) * 1994-07-14 1997-05-07 Smithkline Beecham Farma Derivati eterociclo-condensatori di morfinoidi
HUP9900974A3 (en) * 1996-01-10 2000-09-28 Smithkline Beecham Spa Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU4584100A (en) 2000-11-02
JP2002542247A (ja) 2002-12-10
WO2000063210A1 (en) 2000-10-26
EP1171441A1 (en) 2002-01-16
DE60011417D1 (de) 2004-07-15
ATE268773T1 (de) 2004-06-15
CO5170445A1 (es) 2002-06-27
ITMI990816A1 (it) 2000-10-20
EP1171441B1 (en) 2004-06-09
US6696457B1 (en) 2004-02-24
HK1045150A1 (zh) 2002-11-15

Similar Documents

Publication Publication Date Title
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
IL157563A0 (en) Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers
DE60303238D1 (de) Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
EP2269610A3 (en) Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP2266569A3 (en) Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
WO2009106991A3 (en) Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders
MA30063B1 (fr) Derives pyrimidinyl-aryluree constituant des inhibiteurs des facteurs de croissance des fibroblastes (fcg)
WO2003001982A3 (en) Physiological tissue repair and functional organ regeneration by cultivation of regenerative stem cells in vivo and in situ
BRPI0414455A (pt) métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins
DE602004016729D1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
BRPI0511512A (pt) derivados pirrolpirimidina úteis no tratamento do cáncer
IL158032A (en) Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostics
DE602004006869D1 (de) 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
CO5170445A1 (es) Nuevos compuestos morfinoides,su preparacion y utilizacion
WO2006021002A3 (en) Compounds useful for inhibiting chk1
CA2534634A1 (en) Azolidinecarbonitriles and their use as dpp-iv inhibitors
ATE444069T1 (de) Chinolin-derivate zur behandlung von mglur5- rezeptor-vermittelten erkrankungen
PT1744736E (pt) Método de tratamento de distúrbios do olho seco e uveíte
WO2007041268A3 (en) Transporter-targeted methods of diagnosis and treatment
DE60202446D1 (de) Pharmazeutische formulierung und ihre verwendung für die herstellung eines medikaments zur behandlung von herz-kreislauf-erkrankungen
GB0229022D0 (en) Organic Compounds
WO2004019875A3 (en) Non-invasive methods to identify agents for treating pain
RU2004123072A (ru) Способ лечения больных остеоартрозом